(1)
Zribi, A.; Al Riyami, K.; Al Zahibi, H. S.; Burney, I. A. Managing the Adverse Events Associated With Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer. Sultan Qaboos Univ Med J 2024, 24, 293-297.